Narcolepsy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Narcolepsy is a chronic neurological sleep disorder characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations. It results from the loss of hypocretin/orexin-producing neurons in the hypothalamus.
The study of Narcolepsy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Scammell TE. Narcolepsy. N Engl J Med. 2015;373(27):2654-2662. PMID:26716903
Bassetti CL, Adamantidis A, Burdakov D, et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15(9):519-539. PMID:31367008
Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6(9):991-997. PMID:10973318
Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469-474. PMID:11055430
Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci. 2019;20(2):83-93. PMID:30546102
Kornum BR, Knudsen S, Arlier SN, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100. PMID:28075357
Saper CB, Fuller PM, Pedersen NP. Sleep state switching. Neuron. 2010;68(6):1023-1042. PMID:21172606
Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) deficiency and narcolepsy. Lancet Neurol. 2015;14(3):318-328. PMID:25723983